What is Peripheral Arterial Disease (PAD)?
Peripheral arterial disease (PAD) treatment: drug-coated balloons, self-expanding nitinol stents, covered stent grafts, atherectomy, and CTO crossing systems for leg artery blockage.
Who manufactures Peripheral Arterial Disease (PAD) devices?
INVAMED develops and manufactures a complete range of peripheral arterial disease (pad) devices at its manufacturing and research campus in Ankara, Turkey, with a U.S. office at One World Trade Center, New York. INVAMED technologies are used by physicians in more than 80 countries.
Peripheral Arterial Disease (PAD) product portfolio
The INVAMED peripheral arterial disease (pad) portfolio includes: TemREN Peripheral Atherectomy System, SteerCATH Steerable Catheter, Nexus Venous & Arterial Cannula, Extender Drug PTA Balloon Catheter, Atlas Peripheral Stent System, Atlas Endovascular Stent Graft, Stena Multi-Layer Flow Modulator for Peripheral, DolphinPro Support Catheter, Dolphin PRO Low Profile Crossing Support Catheter, Dolphin ZEBRA Crossing Support Catheter, Dolphin Sub-Intimal Entry Catheter, JaGuar Guiding Sheath, InWIRE Peripheral Guidewires, Keeper Endovascular Snare, AngioTEN Closure Device, Viper ULTRA Thrombolysis Catheter, Invaducer Intraducer.
Frequently Asked Questions about Peripheral Arterial Disease (PAD)
What is a drug-coated balloon for PAD?
A DCB delivers paclitaxel to the arterial wall during angioplasty, inhibiting smooth muscle proliferation causing restenosis. Unlike stents, DCBs leave no permanent implant.
When is atherectomy used in peripheral interventions?
Rotational atherectomy is used for heavily calcified peripheral lesions that resist balloon dilatation. The high-speed burr removes hard plaque as vessel preparation before stenting or DCB.